Cancer Diagnostic firm Exact Sciences in advanced negotiations to acquire Genomic Health Inc for $2.8 billion

A potential could be announced as early as next week.

According to a report from Bloomberg, Exact Sciences Corp, a cancer diagnostics company, is in advanced negotiations to acquire Genomic Health Inc for around $2.8 billion in order to strengthen its cancer testing unit.

The potential deal could be announced as early as next week; however sources have cautioned that negotiations could be delayed, or fall apart.

Neither Exact Sciences nor Genomic Health responded immediately to requests for comments.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s